These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31180618)

  • 1. Phenotypic characterization of haemophilia B - Understanding the underlying biology of coagulation factor IX.
    Tjärnlund-Wolf A; Lassila R
    Haemophilia; 2019 Jul; 25(4):567-574. PubMed ID: 31180618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor IX: Insights from knock-out and genetically engineered mice.
    Monahan PE
    Thromb Haemost; 2008 Oct; 100(4):563-75. PubMed ID: 18841277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of long-acting recombinant fusion protein linking factor IX with albumin in haemophilia B patients undergoing surgery.
    Négrier C; Abdul Karim F; Lepatan LM; Lienhart A; López-Fernández MF; Mahlangu J; Pabinger I; Li Y; Wolko D; Voigt C; Jacobs I; Santagostino E
    Haemophilia; 2016 Jul; 22(4):e259-66. PubMed ID: 27333467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor IX ectopically expressed in platelets can be stored in alpha-granules and corrects the phenotype of hemophilia B mice.
    Zhang G; Shi Q; Fahs SA; Kuether EL; Walsh CE; Montgomery RR
    Blood; 2010 Aug; 116(8):1235-43. PubMed ID: 20445020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Titrating haemophilia B phenotypes using siRNA strategy: evidence that antithrombotic activity is separated from bleeding liability.
    Metzger JM; Tadin-Strapps M; Thankappan A; Strapps WR; DiPietro M; Leander K; Zhang Z; Shin MK; Levorse J; Desai K; Xu Y; Lai K; Wu W; Chen Z; Cai TQ; Jochnowitz N; Bentley R; Hoos L; Zhou Y; Sepp-Lorenzino L; Seiffert D; Andre P
    Thromb Haemost; 2015 Jun; 113(6):1300-11. PubMed ID: 25790442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Haemophilia].
    Loomans JI; Lock J; Peters M; Leebeek FW; Cnossen MH; Fijnvandraat K
    Ned Tijdschr Geneeskd; 2014; 158():A7357. PubMed ID: 25351381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative replacement therapy in haemophilia B: An appeal to "B" more precise.
    Hazendonk HCAM; Preijers T; Liesner R; Chowdary P; Hart D; Keeling D; Driessens MHE; Laros-van Gorkom BAP; van der Meer FJM; Meijer K; Fijnvandraat K; Leebeek FWG; Mathôt RAA; Collins PW; Cnossen MH
    Haemophilia; 2018 Jul; 24(4):611-618. PubMed ID: 29707861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in bleeding phenotype in Amish carriers of haemophilia B with the 31008 C-->T mutation.
    Sharathkumar A; Hardesty B; Greist A; Salter J; Kerlin B; Heiman M; Sulkin M; Shapiro A
    Haemophilia; 2009 Jan; 15(1):91-100. PubMed ID: 18721150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity.
    Perot E; Enjolras N; Le Quellec S; Indalecio A; Girard J; Negrier C; Dargaud Y
    Thromb Res; 2015 May; 135(5):1017-24. PubMed ID: 25795563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
    Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
    Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilia: factoring in new therapies.
    Fassel H; McGuinn C
    Br J Haematol; 2021 Sep; 194(5):835-850. PubMed ID: 34322873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006).
    Chitlur M; Warrier I; Rajpurkar M; Lusher JM
    Haemophilia; 2009 Sep; 15(5):1027-31. PubMed ID: 19515028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic fusion to albumin improves the pharmacokinetic properties of factor IX.
    Metzner HJ; Weimer T; Kronthaler U; Lang W; Schulte S
    Thromb Haemost; 2009 Oct; 102(4):634-44. PubMed ID: 19806248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful in vivo propagation of factor IX-producing hepatocytes in mice: potential for cell-based therapy in haemophilia B.
    Tatsumi K; Ohashi K; Kataoka M; Tateno C; Shibata M; Naka H; Shima M; Hisanaga M; Kanehiro H; Okano T; Yoshizato K; Nakajima Y; Yoshioka A
    Thromb Haemost; 2008 May; 99(5):883-91. PubMed ID: 18449417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a novel extended half-life glycoPEGylated factor IX, nonacog beta pegol (N9-GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials.
    Tiede A; Abdul-Karim F; Carcao M; Persson P; Clausen WHO; Kearney S; Matsushita T; Negrier C; Oldenburg J; Santagostino E; Young G
    Haemophilia; 2017 Jul; 23(4):547-555. PubMed ID: 28233381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia.
    Björkman S; Berntorp E
    Clin Pharmacokinet; 2001; 40(11):815-32. PubMed ID: 11735604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single synonymous mutation in factor IX alters protein properties and underlies haemophilia B.
    Simhadri VL; Hamasaki-Katagiri N; Lin BC; Hunt R; Jha S; Tseng SC; Wu A; Bentley AA; Zichel R; Lu Q; Zhu L; Freedberg DI; Monroe DM; Sauna ZE; Peters R; Komar AA; Kimchi-Sarfaty C
    J Med Genet; 2017 May; 54(5):338-345. PubMed ID: 28007939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and Characterization of Gly-317 Variants of Factor IX Causing Variable Bleeding in Hemophilia B Patients.
    Lu Q; Yang L; Manithody C; Wang X; Rezaie AR
    Biochemistry; 2015 Jun; 54(24):3814-21. PubMed ID: 26023895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of anaphylactic shock in haemophilia B patients with inhibitors.
    Warrier I; Lusher JM
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S125-8. PubMed ID: 9819043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Molecular Basis of FIX Deficiency in Hemophilia B.
    Shen G; Gao M; Cao Q; Li W
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.